These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 28176166)
21. Communicating risks and benefits about ethically controversial topics: the case of induced pluripotent stem (iPS) cells. Longstaff H; McDonald M; Bailey J Stem Cell Rev Rep; 2013 Aug; 9(4):388-96. PubMed ID: 22941397 [TBL] [Abstract][Full Text] [Related]
22. Bioethical aspects of basic research and medical applications of human stem cells. Santos MJ; Ventura-Juncá P Biol Res; 2012; 45(3):317-26. PubMed ID: 23283441 [TBL] [Abstract][Full Text] [Related]
23. Two watershed stem cell experiments: a look back. Scott C Am J Bioeth; 2013; 13(1):17-8. PubMed ID: 23311834 [No Abstract] [Full Text] [Related]
24. Induced pluripotent stem cells: from derivation to application in biochemical and biomedical research. Novosadova EV; Grivennikov IA Biochemistry (Mosc); 2014 Dec; 79(13):1425-41. PubMed ID: 25749158 [TBL] [Abstract][Full Text] [Related]
25. Stem cell research. Chimeric embryos may soon get their day in the sun. Normile D Science; 2013 Jun; 340(6140):1509-10. PubMed ID: 23812693 [No Abstract] [Full Text] [Related]
26. The biopolitics of frozen embryos. Monti M; Redi CA Int J Dev Biol; 2011; 55(3):243-7. PubMed ID: 21710432 [TBL] [Abstract][Full Text] [Related]
28. From naïve pluripotency to chimeras: a new ethical challenge? Hyun I Development; 2015 Jan; 142(1):6-8. PubMed ID: 25516963 [TBL] [Abstract][Full Text] [Related]
29. Traceability in stem cell research: from participant sample to induced pluripotent stem cell and back. Morrison M; Moraia LB; Steele JC Regen Med; 2016 Jan; 11(1):73-9. PubMed ID: 26679283 [TBL] [Abstract][Full Text] [Related]
30. Ethical and legal issues arising in research on inducing human germ cells from pluripotent stem cells. Ishii T; Pera RA; Greely HT Cell Stem Cell; 2013 Aug; 13(2):145-8. PubMed ID: 23910081 [TBL] [Abstract][Full Text] [Related]
31. Broadening the scope of debates around stem cell research. Lysaght T; Campbell AV Bioethics; 2013 Jun; 27(5):251-6. PubMed ID: 22500617 [TBL] [Abstract][Full Text] [Related]
33. We Are Human Beings. McGee A J Med Philos; 2016 Apr; 41(2):148-71. PubMed ID: 26810918 [TBL] [Abstract][Full Text] [Related]
34. Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations. Zimmermann A; Preynat-Seauve O; Tiercy JM; Krause KH; Villard J Stem Cells Dev; 2012 Sep; 21(13):2364-73. PubMed ID: 22559254 [TBL] [Abstract][Full Text] [Related]
35. The inherent ethical challenge of first-in-human pluripotent stem cell trials. Habets MG; van Delden JJ; Bredenoord AL Regen Med; 2014 Jan; 9(1):1-3. PubMed ID: 24350999 [No Abstract] [Full Text] [Related]
36. Derivation of porcine pluripotent stem cells for biomedical research. Shiue YL; Yang JR; Liao YJ; Kuo TY; Liao CH; Kang CH; Tai C; Anderson GB; Chen LR Theriogenology; 2016 Jul; 86(1):176-81. PubMed ID: 27158128 [TBL] [Abstract][Full Text] [Related]
38. Human embryonic and induced pluripotent stem cell research trends: complementation and diversification of the field. Kobold S; Guhr A; Kurtz A; Löser P Stem Cell Reports; 2015 May; 4(5):914-25. PubMed ID: 25866160 [TBL] [Abstract][Full Text] [Related]
39. The European Court of Justice ruling in Brüstle v. Greenpeace: the impacts on patenting of human induced pluripotent stem cells in Europe. Triller Vrtovec K; Scott CT Cell Stem Cell; 2011 Dec; 9(6):502-3. PubMed ID: 22136925 [No Abstract] [Full Text] [Related]